Short answer
ClearPoint Neuro, Inc. (CLPT) filed an 8-K current report with the SEC on May 21, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved the Seventh Amended and Restated 2013 Incentive Compensation Plan, enabling continued equity-based compensation.
ClearPoint Neuro, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved the Seventh Amended and Restated 2013 Incentive Compensation Plan, enabling continued equity-based compensation
- Audit Committee chaired by Lynnette C. Fallon, with R. John Fletcher designated audit committee financial expert
- B. Kristine Johnson appointed Compensation Committee chair, with all members independent and non-employee directors
- R. John Fletcher appointed Governance and Nominating Committee chair and Chairman of the Board
- Committee memberships reflect post-meeting board composition and maintain Nasdaq independence compliance
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Seven director nominees elected to serve through 2027, preserving board continuity
- Cherry Bekaert LLP auditor appointment ratified for fiscal 2026 with 19,296,330 votes for
- Executive compensation advisory vote approved, with 8,825,126 votes for
- Seventh Amended and Restated 2013 Incentive Compensation Plan approved, including 7,517,634 votes for
- 9,991,790 broker non-votes on director, compensation, and incentive-plan proposals limiting shareholder participation interpretation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ClearPoint Neuro, Inc. 8-K filings
Get the next CLPT 8-K as it lands
Follow CLPT for push alerts, or ask the research agent what this filing means.